The company (OTC: AXXA) recently reported the acquisition of Swiss medical supply company MMeditech GmbH, a revenue producing company. From PR- Exxe Group acquired a controlling interest in Swiss medical supply company MMeditech GmbH whose primary revenue drivers are focused on the provision of globally sourced, high-use consumable medical supplies. https://bit.ly/3d2dCG2

From PR- Through the acquisition, immediate revenues to Exxe, a high level of operating profitability, and a $2.8M backlog for 2021 will be generated. https://bit.ly/3d2dCG2

Currently, MMeditech GmbH is on track to generate revenues of $2.7M (vs. $869K in 2019) in 2020, revenues of $3.6M and EBITDA of $1.2M (vs. $328K in 2019) in 2021. https://bit.ly/3d2dCG2

Contact:

SmallCapZone

info@smallcapzone.com

Disclaimer:

All information contained herein as well as on the SmallCapZone.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of SmallCapZone.com and should not be construed as an offer or solicitation to buy or sell securities. The information includes certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks. This report is not without bias. SmallCapZone.com has motivation by means of either self-marketing or SmallCapZone.com has been compensated by or for a company or companies discussed in this article. SmallCapZone.com has not been compensated for this article. You can easily lose money investing in highly speculative small cap/micro-cap stocks like the ones mentioned within. Please consult an investment professional before investing in anything viewed within. When SmallCapZone.com is long shares it will sell those shares.

.

(C) 2020 M2 COMMUNICATIONS, source M2 PressWIRE